Okura T - Search Results

1

Agonist-specific down-regulation of the human delta-opioid receptor.

Okura T, Varga EV, Hosohata Y, Navratilova E, Cowell SM, Rice K, Nagase H, Hruby VJ, Roeske WR, Yamamura HI. Okura T, et al. Eur J Pharmacol. 2003 Jan 10;459(1):9-16. doi: 10.1016/s0014-2999(02)02823-6. Eur J Pharmacol. 2003. PMID: 12505529

2

Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin.

Okura T, Cowell SM, Varga E, Burkey TH, Roeske WR, Hruby VJ, Yamamura HI. Okura T, et al. Eur J Pharmacol. 2000 Jan 10;387(2):R11-3. doi: 10.1016/s0014-2999(99)00761-x. Eur J Pharmacol. 2000. PMID: 10650167

3

Relationship between prostatic alpha(1)-adrenoceptor binding and reduction in intraurethral pressure following continuous infusion of KMD-3213 in rats.

Akiyama K, Tatemichi S, Katayama S, Nakajima M, Oki T, Okura T, Yamada S, Kimura R. Akiyama K, et al. Among authors: okura t. Pharmacology. 2002;64(3):140-7. doi: 10.1159/000056163. Pharmacology. 2002. PMID: 11834890

4

Possible Involvement of Muscarinic Receptor Blockade in Mirabegron Therapy for Patients with Overactive Bladder.

Yamada S, Chimoto J, Shiho M, Okura T, Morikawa K, Wakuda H, Shinozuka K. Yamada S, et al. Among authors: okura t. J Pharmacol Exp Ther. 2021 May;377(2):201-206. doi: 10.1124/jpet.120.000301. Epub 2021 Mar 3. J Pharmacol Exp Ther. 2021. PMID: 33658313

5

In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.

Yamada S, Okura T, Kimura R. Yamada S, et al. Among authors: okura t. J Pharmacol Exp Ther. 2001 Jan;296(1):160-7. J Pharmacol Exp Ther. 2001. PMID: 11123376

6

Selective and sustained occupancy of prostatic alpha1-adrenoceptors by oral administration of KMD-3213 and its plasma concentration in rats.

Okura T, Yamada S, Abe Y, Kimura R. Okura T, et al. J Pharm Pharmacol. 2002 Jul;54(7):975-82. doi: 10.1211/002235702760089108. J Pharm Pharmacol. 2002. PMID: 12162717

7

Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.

Okura T, Saito M, Nakanishi M, Komiyama N, Fujii A, Yamada S, Kimura R. Okura T, et al. Br J Pharmacol. 2003 Sep;140(1):211-7. doi: 10.1038/sj.bjp.0705418. Epub 2003 Aug 4. Br J Pharmacol. 2003. PMID: 12967951 Free PMC article.

8

Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.

Yamada S, Kato Y, Okura T, Kagawa Y, Kawabe K. Yamada S, et al. Among authors: okura t. Biol Pharm Bull. 2007 Jul;30(7):1237-41. doi: 10.1248/bpb.30.1237. Biol Pharm Bull. 2007. PMID: 17603160 Free article.

9

Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.

Okura T, Morita Y, Ito Y, Kagawa Y, Yamada S. Okura T, et al. J Pharm Pharmacol. 2009 May;61(5):593-7. doi: 10.1211/jpp/61.05.0007. J Pharm Pharmacol. 2009. PMID: 19405997

10

Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues.

Yamada S, Okura T, Kimura R, Deguchi Y, Suzuki Y, Kobayashi T, Aisaka K. Yamada S, et al. Among authors: okura t. Drug Metab Dispos. 2000 Dec;28(12):1487-92. Drug Metab Dispos. 2000. PMID: 11095588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters